ArticleHuman cell2023
Possible role of combined therapy targeting MET and pro-HGF activation for renal cell carcinoma: analysis by human HGF-producing SCID mice.
Masato Fujii et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it